Pharmaceuticals and Biotechnology
Healthcare Services
Healthcare Devices and Supplies
Medical Technology Systems
-34%
109
69
75
111
131
87
72
110
185
98
76
106
182
117
91
162
211
115
89
178
319
179
119
275
291
210
107
289
195
135
98
163
364
400
465
552
593
892
897
591
1. Deal counts include M&A, rounds of funding, and buybacks that were completed in the US
2. June 30th 2023
Source: S&P, Oliver Wyman Analysis